Key influences on the decision to initiate PrEP among adolescent girls and young women within routine maternal child health and family planning clinics in Western Kenya.
Africa
HIV prevention
PrEP
Pre-exposure prophylaxis
adolescents
women
Journal
AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
pubmed:
21
9
2021
medline:
5
4
2022
entrez:
20
9
2021
Statut:
ppublish
Résumé
We sought to understand influences on PrEP uptake among Kenyan adolescent girls and young women (AGYW) whose decision on PrEP use was misaligned with their risk for HIV acquisition. In-depth interviews were conducted with 47 Kenyan HIV-negative AGYW aged 15-24 years who were offered PrEP during routine maternal and child health and family planning services. AGYW were sampled from two groups (1) declined PrEP and had ≥1 sexual partner(s) of unknown HIV status and (2) initiated PrEP and reported having one HIV-negative partner. AGYW with HIV-negative partners initiated PrEP due to known or suspected infidelity. AGYW with partners of unknown HIV status recognized PrEP as a helpful HIV prevention tool, yet worried about partner reactions and prioritized avoiding uncomfortable or unsafe situations over PrEP. Among pregnant AGYW, the responsibility of motherhood and providing a future for one's family, through staying healthy and remaining HIV-free, was a strong PrEP use motivator. Among AGYW who desired future motherhood, fears that PrEP could negatively impact fertility or reduce contraceptive effectiveness led to declining PrEP. Peers positively influenced PrEP decision-making, especially personally knowing a PrEP user. Strategies are needed to enhance messaging and delivery approaches that are tailored to AGYW, including peer-led strategies.
Identifiants
pubmed: 34543077
doi: 10.1080/09540121.2021.1981217
pmc: PMC8934309
mid: NIHMS1741889
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
363-370Subventions
Organisme : NICHD NIH HHS
ID : R01 HD094630
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI125498
Pays : United States
Organisme : NINR NIH HHS
ID : R01 NR019220
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD100201
Pays : United States
Références
J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):259-265
pubmed: 28777265
PLoS One. 2014 Feb 21;9(2):e89118
pubmed: 24586534
Lancet HIV. 2020 Jan;7(1):e38-e48
pubmed: 31813837
BMC Public Health. 2020 Jun 26;20(1):1016
pubmed: 32590969
Sex Health. 2018 Nov;15(6):513-521
pubmed: 30408431
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):590-595
pubmed: 30204720
Am J Health Promot. 1997 Sep-Oct;12(1):38-48
pubmed: 10170434
JAMA. 2014 Jul 23-30;312(4):362-71
pubmed: 25038355
AIDS Behav. 2018 Aug;22(8):2662-2673
pubmed: 29560570
J Int AIDS Soc. 2020 Jun;23(6):e25536
pubmed: 32524700
AIDS Behav. 2017 Feb;21(2):481-491
pubmed: 27858268
AIDS Behav. 2015 May;19(5):784-93
pubmed: 25416076
AIDS Patient Care STDS. 2018 Dec;32(12):538-544
pubmed: 30036072
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
J Acquir Immune Defic Syndr. 2017 May 1;75(1):91-96
pubmed: 28399558
BMJ Open. 2019 Dec 23;9(12):e033435
pubmed: 31874891
AIDS Behav. 2019 Aug;23(8):2185-2189
pubmed: 30666522
J Int AIDS Soc. 2020 Jun;23(6):e25528
pubmed: 32544303
J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25298
pubmed: 31328444
AIDS. 2014 Jul 31;28(12):1825-30
pubmed: 24785951
J Acquir Immune Defic Syndr. 2020 Oct 1;85(2):182-188
pubmed: 32568766
Annu Rev Med. 2020 Jan 27;71:361-377
pubmed: 31613684
J Int AIDS Soc. 2018 Aug;21(8):e25170
pubmed: 30152004
AIDS. 2015 Nov;29(17):2353-9
pubmed: 26544706
J Int AIDS Soc. 2016 May 30;19(1):20875
pubmed: 27247202
AIDS Care. 2020 Oct;32(10):1290-1294
pubmed: 32576023
PLoS Med. 2019 Sep 3;16(9):e1002885
pubmed: 31479452